96 results
8-K
VBIV
VBI Vaccines Inc.
3 Apr 24
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
8:00am
and/or distribute to the investment community and utilize the slide presentation at various industry and other conferences. A copy of the press release
8-K
h7w8e z350z7ne
27 Dec 22
Regulation FD Disclosure
8:00am